
Alert: New Earnings Report (3/19/25)-Capricor Therapeutics Inc (NASDAQ: CAPR).
Capricor Therapeutics Inc (NASDAQ: CAPR) has reported E.P.S. of $-0.16 for its fourth fiscal quarter (ending December 31) versus $-0.02 for the same period a year ago — an increase of 700%. For the latest […]